Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c+ Expression in Tumor

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · International Journal of Cancer · 2018 · 7.6K citations · Full text

Global Cancer Incidence, Cancer Management, Epidemiology Of Cancer +20

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

Martin Köbel, Steve E. Kalloger, Niki Boyd et al. · PLoS Medicine · 2008 · 812 citations · Full text

Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis

Francesca Romana Bertani, Pamela Mozetic, Marco Fioramonti et al. · Scientific Reports · 2017 · 227 citations · Full text

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

Wen‐Fang Cheng, C-Y Huang, M‐C Chang et al. · British Journal of Cancer · 2009 · 171 citations · Full text

Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma

M. Jim Yen, Chih-Yi Hsu, Tsui‐Lien Mao et al. · Clinical Cancer Research · 2006 · 96 citations · Full text